PA and TR were involved with the consensus concept and design, acquisition of data, drafting of the manuscript, critical revision of the manuscript,

and participation in electronic and face-to-face voting. CK, RP, JM, DS, LP, AS, PP, TA, DR, AM, SP, PK, MR, and MK were involved with drafting of the manuscript, critical revision of the manuscript, and participation in electronic and face-to-face voting. TI was involved with drafting of the manuscript, critical revision of the manuscript, and participation in electronic voting. NP, ST, SA, BD, HW, EO, DL, and PM were involved with critical revision of the manuscript, and participation MAPK inhibitor in electronic and face-to-face voting. KG and BO were involved with

critical revision of the manuscript and participation in electronic voting. SC and AJ were involved with study supervision and participation in electronic voting. VB was involved with study supervision. Surgeon—Amit Maydeo, Thawatchai Akaraviputh, Thawee Rattanachu-ek, AZD6738 ic50 Vajarabhongsa Bhudhisawasdi Gastroenterologist—Rungsun Rerknimitr, Pises Pisespongsa, Takao Itoi, Christopher J L Khor, Ryan Ponnudurai, Jong H Moon, Dong Wan Seo, Duvvuru Nageshwar Reddy, Apichat Sangchan, Pradermchai Kongkam, Nonthalee Pausawasdi, Siriboon Attasaranya, Dong Ki Lee, Bancha Ovartlarnporn, Suraphol Churnratanakul, Kean-Lee Goh, Benedict Devereaux,

Hsiu-Po Wang, Evan Ong, Sombat Treeprasertsuk, Maylene Kok Diagnostic radiologist—Linda Pantongrag-Brown Interventional radiologist—Sundeep Punamiya, Akkawat Janchai Surgeon—Amit Maydeo, Thawatchai Akaraviputh, Thawee Rattanachu-ek Gastroenterologist—Rungsun Rerknimitr, Pises Pisespongsa, Christopher J L Khor, Ryan Ponnudurai, Jong H Moon, Dong Wan Seo, Apichat Sangchan, Pradermchai Kongkam, Nonthalee Pausawasdi, Siriboon Attasaranya, Dong Ki Lee, Benedict Devereaux, Hsiu-Po Wang, Evan Ong, Sombat Treeprasertsuk, Mohan Ramchandani, Maylene Kok Diagnostic radiologist—Linda Pantongrag-Brown Interventional radiologist—Sundeep Punamiya selleck inhibitor (All face-to-face meeting participants participated in the first two electronic votes) Members of the group were selected by the following criteria: Demonstration of knowledge/expertise in HCCA by publication/research or participate in national or regional guidelines. Geographical representation of the Asia–Pacific countries/region. Diversity of clinical views on management of HCCA (limited to clinicians). Representative countries were Australia, Malaysia, India, Taiwan, the Philippines, South Korea, Japan, Singapore, and Thailand. Representatives from China, New Zealand, and Indonesia were invited but did not participate.